Advanced Enzyme Technologies Ltd.
•₹ 300-0.99%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2024 • Human Nutrition: 67.2% • Bio-Process: 20.9% • Animal Nutrition: 10.8% • Sale Of Services: 1.0% • Other Operating Revenues: 0.1%
PROS
- Company is almost debt free
- Company has consistently been profitable over the last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.99x)
- Company has been maintaining a healthy dividend payout of 35.5%
- Company comfortably covers its interest (63.3x coverage)
- Company generates healthy free cash flow
CONS
- Company has delivered a poor profit growth of 2.8% over past five years
- Recurring exceptional / one-off items are inflating headline profit
- Operating margins have contracted to 30.7% from 33.8%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ADVENZYMES | 305.30 | 20.61 | 3418.63 | 1.75 | 38.59 | -4.58 | 189.79 | 2.09 | 15.27 | 26.85 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 147 | 158 | 161 | 158 | 155 | 146 | 169 | 167 | 186 | 185 | 172 | 203 | 190 | |
| 103 | 107 | 107 | 102 | 103 | 104 | 114 | 122 | 129 | 124 | 123 | 140 | 149 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 7 | 6 | 14 | 10 | 7 | 10 | 8 | 9 | 9 | 10 | 8 | 7 | 13 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 |
| 41 | 48 | 59 | 40 | 49 | 42 | 53 | 43 | 55 | 60 | 58 | 60 | 54 | |
| Tax % | 29.05% | 26.56% | 27.82% | 24.59% | 28.15% | 20.90% | 26.69% | 38.50% | 26.34% | 24.87% | 25.92% | 24.33% | 27.91% |
| Net Profit | 0 | 0 | 0 | 0 | 35 | 33 | 39 | 27 | 40 | 45 | 43 | 45 | 39 |
| 3 | 3 | 4 | 3 | 3 | 3 | 3 | 2 | 4 | 4 | 4 | 4 | 0 | |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 147
- 103
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 9
- 41
- Tax %
- 29.05%
- Net Profit
- 0
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 158
- 107
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 9
- 48
- Tax %
- 26.56%
- Net Profit
- 0
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 161
- 107
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 1
- Depreciation
- 9
- 59
- Tax %
- 27.82%
- Net Profit
- 0
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 158
- 102
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 1
- Depreciation
- 9
- 40
- Tax %
- 24.59%
- Net Profit
- 0
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 155
- 103
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 9
- 49
- Tax %
- 28.15%
- Net Profit
- 35
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 146
- 104
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 1
- Depreciation
- 9
- 42
- Tax %
- 20.90%
- Net Profit
- 33
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 169
- 114
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 1
- Depreciation
- 9
- 53
- Tax %
- 26.69%
- Net Profit
- 39
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 167
- 122
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 1
- Depreciation
- 10
- 43
- Tax %
- 38.50%
- Net Profit
- 27
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 186
- 129
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 1
- Depreciation
- 10
- 55
- Tax %
- 26.34%
- Net Profit
- 40
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 185
- 124
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 1
- Depreciation
- 10
- 60
- Tax %
- 24.87%
- Net Profit
- 45
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 172
- 123
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 1
- Depreciation
- 10
- 58
- Tax %
- 25.92%
- Net Profit
- 43
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 203
- 140
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 10
- 60
- Tax %
- 24.33%
- Net Profit
- 45
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 190
- 149
- Operating Profit
- —
- OPM %
- —
- Other Income
- 13
- Interest
- 1
- Depreciation
- 10
- 54
- Tax %
- 27.91%
- Net Profit
- 39
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 329 | 391 | 420 | 444 | 502 | 529 | 541 | 624 | 637 | 746 | 750 | |
| 178 | 227 | 237 | 241 | 269 | 327 | 383 | 419 | 441 | 516 | 536 | |
| Operating Profit | 154 | 166 | 188 | 209 | 241 | 209 | 183 | 242 | 229 | 265 | — |
| OPM % | 47 | 43 | 45 | 47 | 48 | 39 | 34 | 39 | 36 | 36 | — |
| Other Income | 3 | 3 | 6 | 6 | 9 | 6 | 25 | 37 | 33 | 36 | 39 |
| Interest | 4 | 9 | 5 | 4 | 3 | 3 | 3 | 4 | 5 | 4 | 2 |
| Depreciation | 13 | 18 | 21 | 26 | 29 | 35 | 35 | 35 | 37 | 40 | 40 |
| 137 | 139 | 162 | 179 | 210 | 171 | 140 | 188 | 187 | 233 | 231 | |
| Tax % | 32 | 33 | 28 | 26 | 28 | 28 | 26 | 27 | 28 | 25 | 26 |
| Net Profit | 93 | 94 | 116 | 133 | 151 | 124 | 104 | 137 | 134 | 174 | 172 |
| EPS | 8 | 8 | 10 | 12 | 13 | 11 | 9 | 12 | 12 | 15 | — |
| Dividend Payout % | 5 | 6 | 6 | 5 | 7 | 9 | 11 | 43 | 44 | 35 | — |
| Minority Interest | -1 | -3 | -5 | -4 | -5 | -4 | 2 | -4 | -3 | -5 | 1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 8 | 10 | 12 | 13 | 11 | 9 | 12 | 12 | 15 | — |
| Minority Interest | -1 | -3 | -5 | -4 | -5 | -4 | 2 | -4 | -3 | -5 | 1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 8 | 10 | 12 | 13 | 11 | 9 | 12 | 12 | 15 | — |
Mar 2017
- 329
- 178
- Operating Profit
- 154
- OPM %
- 47
- Other Income
- 3
- Interest
- 4
- Depreciation
- 13
- 137
- Tax %
- 32
- Net Profit
- 93
- EPS
- 8
- Dividend Payout %
- 5
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2018
- 391
- 227
- Operating Profit
- 166
- OPM %
- 43
- Other Income
- 3
- Interest
- 9
- Depreciation
- 18
- 139
- Tax %
- 33
- Net Profit
- 94
- EPS
- 8
- Dividend Payout %
- 6
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2019
- 420
- 237
- Operating Profit
- 188
- OPM %
- 45
- Other Income
- 6
- Interest
- 5
- Depreciation
- 21
- 162
- Tax %
- 28
- Net Profit
- 116
- EPS
- 10
- Dividend Payout %
- 6
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2020
- 444
- 241
- Operating Profit
- 209
- OPM %
- 47
- Other Income
- 6
- Interest
- 4
- Depreciation
- 26
- 179
- Tax %
- 26
- Net Profit
- 133
- EPS
- 12
- Dividend Payout %
- 5
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2021
- 502
- 269
- Operating Profit
- 241
- OPM %
- 48
- Other Income
- 9
- Interest
- 3
- Depreciation
- 29
- 210
- Tax %
- 28
- Net Profit
- 151
- EPS
- 13
- Dividend Payout %
- 7
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2022
- 529
- 327
- Operating Profit
- 209
- OPM %
- 39
- Other Income
- 6
- Interest
- 3
- Depreciation
- 35
- 171
- Tax %
- 28
- Net Profit
- 124
- EPS
- 11
- Dividend Payout %
- 9
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 11
Mar 2023
- 541
- 383
- Operating Profit
- 183
- OPM %
- 34
- Other Income
- 25
- Interest
- 3
- Depreciation
- 35
- 140
- Tax %
- 26
- Net Profit
- 104
- EPS
- 9
- Dividend Payout %
- 11
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2024
- 624
- 419
- Operating Profit
- 242
- OPM %
- 39
- Other Income
- 37
- Interest
- 4
- Depreciation
- 35
- 188
- Tax %
- 27
- Net Profit
- 137
- EPS
- 12
- Dividend Payout %
- 43
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2025
- 637
- 441
- Operating Profit
- 229
- OPM %
- 36
- Other Income
- 33
- Interest
- 5
- Depreciation
- 37
- 187
- Tax %
- 28
- Net Profit
- 134
- EPS
- 12
- Dividend Payout %
- 44
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2026
- 746
- 516
- Operating Profit
- 265
- OPM %
- 36
- Other Income
- 36
- Interest
- 4
- Depreciation
- 40
- 233
- Tax %
- 25
- Net Profit
- 174
- EPS
- 15
- Dividend Payout %
- 35
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 15
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- 15
TTM
- 750
- 536
- Operating Profit
- —
- OPM %
- —
- Other Income
- 39
- Interest
- 2
- Depreciation
- 40
- 231
- Tax %
- 26
- Net Profit
- 172
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 10%
- 5 Years:
- 8%
- 3 Years:
- 11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 8%
- 5 Years:
- 3%
- 3 Years:
- 17%
STOCK PRICE CAGR
- 10 Years:
- 1%
- 5 Years:
- -4%
- 3 Years:
- -3%
- 1 Year:
- -2%
RETURN ON EQUITY
- 10 Years:
- 15%
- 5 Years:
- 11%
- 3 Years:
- 11%
- Last Year:
- 11%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| 441 | 534 | 653 | 814 | 946 | 1,066 | 1,213 | 1,299 | 1,394 | 1,600 | |
| 27 | 46 | 21 | 13 | 9 | 3 | 5 | 18 | 11 | 11 | |
| Trade Payables | 11 | 17 | 10 | 10 | 15 | 18 | 24 | 16 | 19 | 40 |
| 81 | 108 | 99 | 113 | 157 | 152 | 146 | 167 | 165 | 160 | |
| Total Liabilities | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,521 | 1,611 | 1,834 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 421 | 491 | 495 | 563 | 604 | 619 | 649 | 650 | 679 | 692 | |
| Capital Work in Progress | 1 | 3 | 5 | 5 | 5 | 10 | 16 | 31 | 22 | 51 |
| 0 | 0 | 111 | 124 | 121 | 102 | 360 | 403 | 480 | 584 | |
| 68 | 76 | 77 | 80 | 94 | 121 | 124 | 148 | 157 | 177 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99 | 115 | 145 | |
| Cash & Bank | 8 | 61 | 23 | 83 | 198 | 274 | 123 | 127 | 108 | 116 |
| 83 | 96 | 94 | 117 | 127 | 135 | 139 | 64 | 50 | 68 | |
| Total Assets | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,521 | 1,611 | 1,834 |
| Total Debt | 54 | 67 | 35 | 26 | 19 | 11 | 13 | 25 | 22 | 21 |
| Net Working Capital | 76 | 112 | 217 | 316 | 448 | 544 | 645 | 703 | 784 | 937 |
| Contingent Liabilities | 25 | 29 | 29 | 14 | 11 | 13 | 5 | 5 | 9 | 8 |
| Book Value per Share | 207.71 | 49.85 | 60.49 | 74.86 | 86.67 | 97.31 | 110.45 | 118.14 | 126.56 | 144.99 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 54 | 67 | 35 | 26 | 19 | 11 | 13 | 25 | 22 | 21 |
| Net Working Capital | 76 | 112 | 217 | 316 | 448 | 544 | 645 | 703 | 784 | 937 |
| Contingent Liabilities | 25 | 29 | 29 | 14 | 11 | 13 | 5 | 5 | 9 | 8 |
| Book Value per Share | 207.71 | 49.85 | 60.49 | 74.86 | 86.67 | 97.31 | 110.45 | 118.14 | 126.56 | 144.99 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- Equity Capital
- 22
- 441
- 27
- Trade Payables
- 11
- 81
- Total Liabilities
- 583
- 421
- Capital Work in Progress
- 1
- 0
- 68
- 0
- Cash & Bank
- 8
- 83
- Total Assets
- 583
- Total Debt
- 54
- Net Working Capital
- 76
- Contingent Liabilities
- 25
- Book Value per Share
- 207.71
- Face Value
- 10.00
- Total Debt
- 54
- Net Working Capital
- 76
- Contingent Liabilities
- 25
- Book Value per Share
- 207.71
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 22
- 534
- 46
- Trade Payables
- 17
- 108
- Total Liabilities
- 727
- 491
- Capital Work in Progress
- 3
- 0
- 76
- 0
- Cash & Bank
- 61
- 96
- Total Assets
- 727
- Total Debt
- 67
- Net Working Capital
- 112
- Contingent Liabilities
- 29
- Book Value per Share
- 49.85
- Face Value
- 2.00
- Total Debt
- 67
- Net Working Capital
- 112
- Contingent Liabilities
- 29
- Book Value per Share
- 49.85
- Face Value
- 2.00
Mar 2019
- Equity Capital
- 22
- 653
- 21
- Trade Payables
- 10
- 99
- Total Liabilities
- 805
- 495
- Capital Work in Progress
- 5
- 111
- 77
- 0
- Cash & Bank
- 23
- 94
- Total Assets
- 805
- Total Debt
- 35
- Net Working Capital
- 217
- Contingent Liabilities
- 29
- Book Value per Share
- 60.49
- Face Value
- 2.00
- Total Debt
- 35
- Net Working Capital
- 217
- Contingent Liabilities
- 29
- Book Value per Share
- 60.49
- Face Value
- 2.00
Mar 2020
- Equity Capital
- 22
- 814
- 13
- Trade Payables
- 10
- 113
- Total Liabilities
- 971
- 563
- Capital Work in Progress
- 5
- 124
- 80
- 0
- Cash & Bank
- 83
- 117
- Total Assets
- 971
- Total Debt
- 26
- Net Working Capital
- 316
- Contingent Liabilities
- 14
- Book Value per Share
- 74.86
- Face Value
- 2.00
- Total Debt
- 26
- Net Working Capital
- 316
- Contingent Liabilities
- 14
- Book Value per Share
- 74.86
- Face Value
- 2.00
Mar 2021
- Equity Capital
- 22
- 946
- 9
- Trade Payables
- 15
- 157
- Total Liabilities
- 1,149
- 604
- Capital Work in Progress
- 5
- 121
- 94
- 0
- Cash & Bank
- 198
- 127
- Total Assets
- 1,149
- Total Debt
- 19
- Net Working Capital
- 448
- Contingent Liabilities
- 11
- Book Value per Share
- 86.67
- Face Value
- 2.00
- Total Debt
- 19
- Net Working Capital
- 448
- Contingent Liabilities
- 11
- Book Value per Share
- 86.67
- Face Value
- 2.00
Mar 2022
- Equity Capital
- 22
- 1,066
- 3
- Trade Payables
- 18
- 152
- Total Liabilities
- 1,260
- 619
- Capital Work in Progress
- 10
- 102
- 121
- 0
- Cash & Bank
- 274
- 135
- Total Assets
- 1,260
- Total Debt
- 11
- Net Working Capital
- 544
- Contingent Liabilities
- 13
- Book Value per Share
- 97.31
- Face Value
- 2.00
- Total Debt
- 11
- Net Working Capital
- 544
- Contingent Liabilities
- 13
- Book Value per Share
- 97.31
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 22
- 1,213
- 5
- Trade Payables
- 24
- 146
- Total Liabilities
- 1,411
- 649
- Capital Work in Progress
- 16
- 360
- 124
- 0
- Cash & Bank
- 123
- 139
- Total Assets
- 1,411
- Total Debt
- 13
- Net Working Capital
- 645
- Contingent Liabilities
- 5
- Book Value per Share
- 110.45
- Face Value
- 2.00
- Total Debt
- 13
- Net Working Capital
- 645
- Contingent Liabilities
- 5
- Book Value per Share
- 110.45
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 22
- 1,299
- 18
- Trade Payables
- 16
- 167
- Total Liabilities
- 1,521
- 650
- Capital Work in Progress
- 31
- 403
- 148
- 99
- Cash & Bank
- 127
- 64
- Total Assets
- 1,521
- Total Debt
- 25
- Net Working Capital
- 703
- Contingent Liabilities
- 5
- Book Value per Share
- 118.14
- Face Value
- 2.00
- Total Debt
- 25
- Net Working Capital
- 703
- Contingent Liabilities
- 5
- Book Value per Share
- 118.14
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 22
- 1,394
- 11
- Trade Payables
- 19
- 165
- Total Liabilities
- 1,611
- 679
- Capital Work in Progress
- 22
- 480
- 157
- 115
- Cash & Bank
- 108
- 50
- Total Assets
- 1,611
- Total Debt
- 22
- Net Working Capital
- 784
- Contingent Liabilities
- 9
- Book Value per Share
- 126.56
- Face Value
- 2.00
- Total Debt
- 22
- Net Working Capital
- 784
- Contingent Liabilities
- 9
- Book Value per Share
- 126.56
- Face Value
- 2.00
Mar 2026
- Equity Capital
- 22
- 1,600
- 11
- Trade Payables
- 40
- 160
- Total Liabilities
- 1,834
- 692
- Capital Work in Progress
- 51
- 584
- 177
- 145
- Cash & Bank
- 116
- 68
- Total Assets
- 1,834
- Total Debt
- 21
- Net Working Capital
- 937
- Contingent Liabilities
- 8
- Book Value per Share
- 144.99
- Face Value
- 2.00
- Total Debt
- 21
- Net Working Capital
- 937
- Contingent Liabilities
- 8
- Book Value per Share
- 144.99
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 107 | 116 | 129 | 141 | 163 | 122 | 140 | 141 | 142 | 157 | |
| Cash from Investing | -60 | -78 | -125 | -44 | -26 | -4 | -298 | -65 | -89 | -74 |
| Cash from Financing | -65 | -2 | -43 | -39 | -26 | -48 | -26 | -59 | -73 | -70 |
| -18 | 36 | -39 | 58 | 111 | 70 | -184 | 17 | -19 | 12 | |
| Free Cash Flow | 20 | -1 | 101 | 46 | 88 | 68 | 72 | 92 | 88 | 75 |
| OCF / Net Profit | 1.16 | 1.24 | 1.11 | 1.06 | 1.08 | 0.99 | 1.35 | 1.03 | 1.06 | 0.90 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 254 | 302 | 375 | 366 | 408 | 395 |
| OCF / Net Profit | 1.16 | 1.24 | 1.11 | 1.06 | 1.08 | 0.99 | 1.35 | 1.03 | 1.06 | 0.90 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 254 | 302 | 375 | 366 | 408 | 395 |
Mar 2017
- 107
- Cash from Investing
- -60
- Cash from Financing
- -65
- -18
- Free Cash Flow
- 20
- OCF / Net Profit
- 1.16
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.16
- Cumulative 5-Year FCF
- 0
Mar 2018
- 116
- Cash from Investing
- -78
- Cash from Financing
- -2
- 36
- Free Cash Flow
- -1
- OCF / Net Profit
- 1.24
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.24
- Cumulative 5-Year FCF
- 0
Mar 2019
- 129
- Cash from Investing
- -125
- Cash from Financing
- -43
- -39
- Free Cash Flow
- 101
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
Mar 2020
- 141
- Cash from Investing
- -44
- Cash from Financing
- -39
- 58
- Free Cash Flow
- 46
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 0
Mar 2021
- 163
- Cash from Investing
- -26
- Cash from Financing
- -26
- 111
- Free Cash Flow
- 88
- OCF / Net Profit
- 1.08
- Cumulative 5-Year FCF
- 254
- OCF / Net Profit
- 1.08
- Cumulative 5-Year FCF
- 254
Mar 2022
- 122
- Cash from Investing
- -4
- Cash from Financing
- -48
- 70
- Free Cash Flow
- 68
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- 302
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- 302
Mar 2023
- 140
- Cash from Investing
- -298
- Cash from Financing
- -26
- -184
- Free Cash Flow
- 72
- OCF / Net Profit
- 1.35
- Cumulative 5-Year FCF
- 375
- OCF / Net Profit
- 1.35
- Cumulative 5-Year FCF
- 375
Mar 2024
- 141
- Cash from Investing
- -65
- Cash from Financing
- -59
- 17
- Free Cash Flow
- 92
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 366
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 366
Mar 2025
- 142
- Cash from Investing
- -89
- Cash from Financing
- -73
- -19
- Free Cash Flow
- 88
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 408
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 408
Mar 2026
- 157
- Cash from Investing
- -74
- Cash from Financing
- -70
- 12
- Free Cash Flow
- 75
- OCF / Net Profit
- 0.90
- Cumulative 5-Year FCF
- 395
- OCF / Net Profit
- 0.90
- Cumulative 5-Year FCF
- 395
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 41.00 | 8.08 | 9.95 | 11.58 | 13.06 | 10.70 | 9.45 | 11.92 | 11.72 | 15.07 |
| Book Value (₹) | 207.71 | 49.85 | 60.49 | 74.86 | 86.67 | 97.31 | 110.45 | 118.14 | 126.56 | 144.99 |
| Dividend per Share (₹) | 2.00 | 0.50 | 0.60 | 0.60 | 0.90 | 1.00 | 1.00 | 5.10 | 5.20 | 5.35 |
| Cash EPS (₹) | 9.47 | 10.02 | 12.27 | 14.22 | 16.11 | 14.20 | 12.42 | 15.40 | 15.24 | 19.09 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 44.96% | 42.04% | 44.87% | 47.06% | 48.52% | 39.40% | 33.79% | 32.87% | 30.70% | 30.69% |
| Net Margin % | 27.09% | 23.65% | 27.62% | 29.96% | 30.41% | 23.34% | 19.18% | 21.92% | 21.04% | 23.24% |
| ROE % | 25.06% | 18.34% | 18.82% | 17.61% | 16.77% | 12.04% | 8.94% | 10.72% | 9.79% | 11.43% |
| ROCE % | 31.53% | 25.88% | 24.96% | 23.21% | 22.93% | 16.66% | 12.26% | 14.78% | 13.76% | 15.27% |
| 18.00% | 14.28% | 15.13% | 14.98% | 14.27% | 10.28% | 7.78% | 9.34% | 8.55% | 10.08% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 49 | 50 | 51 | 55 | 59 | 60 | 64 | 58 | 61 | 64 |
| Inventory Days | 69 | 66 | 66 | 64 | 64 | 74 | 83 | 80 | 88 | 82 |
| Payable Days | 58 | 64 | 64 | 44 | 46 | 55 | 58 | 50 | 42 | 56 |
| 59 | 53 | 53 | 76 | 77 | 79 | 88 | 87 | 107 | 89 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.12x | 0.12x | 0.05x | 0.03x | 0.02x | 0.01x | 0.01x | 0.02x | 0.02x | 0.01x |
| Interest Coverage (x) | 31.91x | 16.34x | 32.13x | 44.94x | 82.76x | 58.89x | 41.36x | 46.58x | 41.44x | 63.28x |
| 2.24x | 2.13x | 4.33x | 6.31x | 7.64x | 10.00x | 9.31x | 7.61x | 9.14x | 9.78x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 11.99% | 18.85% | 7.31% | 5.81% | 13.03% | 5.49% | 2.13% | 15.39% | 2.09% | 17.09% |
| Operating Profit Growth % | 11.09% | 7.83% | 13.20% | 11.01% | 15.51% | -13.43% | -12.46% | 32.44% | -5.68% | 15.95% |
| Net Profit Growth % | 21.10% | 0.66% | 23.89% | 14.79% | 13.71% | -18.17% | -16.10% | 31.85% | -2.17% | 29.58% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.19% | -1.69% | 28.63% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 29.15x | 23.80x | 16.94x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.94x | 2.20x | 1.76x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.47% | 1.86% | 2.09% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 15.62x | 13.28x | 10.43x |
Mar 2017
- EPS (₹)
- 41.00
- Book Value (₹)
- 207.71
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 9.47
- Operating Margin %
- 44.96%
- Net Margin %
- 27.09%
- ROE %
- 25.06%
- ROCE %
- 31.53%
- 18.00%
- Debtor Days
- 49
- Inventory Days
- 69
- Payable Days
- 58
- 59
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 31.91x
- 2.24x
- Revenue Growth %
- 11.99%
- Operating Profit Growth %
- 11.09%
- Net Profit Growth %
- 21.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 8.08
- Book Value (₹)
- 49.85
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 10.02
- Operating Margin %
- 42.04%
- Net Margin %
- 23.65%
- ROE %
- 18.34%
- ROCE %
- 25.88%
- 14.28%
- Debtor Days
- 50
- Inventory Days
- 66
- Payable Days
- 64
- 53
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 16.34x
- 2.13x
- Revenue Growth %
- 18.85%
- Operating Profit Growth %
- 7.83%
- Net Profit Growth %
- 0.66%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 9.95
- Book Value (₹)
- 60.49
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 12.27
- Operating Margin %
- 44.87%
- Net Margin %
- 27.62%
- ROE %
- 18.82%
- ROCE %
- 24.96%
- 15.13%
- Debtor Days
- 51
- Inventory Days
- 66
- Payable Days
- 64
- 53
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 32.13x
- 4.33x
- Revenue Growth %
- 7.31%
- Operating Profit Growth %
- 13.20%
- Net Profit Growth %
- 23.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 11.58
- Book Value (₹)
- 74.86
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 14.22
- Operating Margin %
- 47.06%
- Net Margin %
- 29.96%
- ROE %
- 17.61%
- ROCE %
- 23.21%
- 14.98%
- Debtor Days
- 55
- Inventory Days
- 64
- Payable Days
- 44
- 76
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 44.94x
- 6.31x
- Revenue Growth %
- 5.81%
- Operating Profit Growth %
- 11.01%
- Net Profit Growth %
- 14.79%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 13.06
- Book Value (₹)
- 86.67
- Dividend per Share (₹)
- 0.90
- Cash EPS (₹)
- 16.11
- Operating Margin %
- 48.52%
- Net Margin %
- 30.41%
- ROE %
- 16.77%
- ROCE %
- 22.93%
- 14.27%
- Debtor Days
- 59
- Inventory Days
- 64
- Payable Days
- 46
- 77
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 82.76x
- 7.64x
- Revenue Growth %
- 13.03%
- Operating Profit Growth %
- 15.51%
- Net Profit Growth %
- 13.71%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 10.70
- Book Value (₹)
- 97.31
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 14.20
- Operating Margin %
- 39.40%
- Net Margin %
- 23.34%
- ROE %
- 12.04%
- ROCE %
- 16.66%
- 10.28%
- Debtor Days
- 60
- Inventory Days
- 74
- Payable Days
- 55
- 79
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 58.89x
- 10.00x
- Revenue Growth %
- 5.49%
- Operating Profit Growth %
- -13.43%
- Net Profit Growth %
- -18.17%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 9.45
- Book Value (₹)
- 110.45
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 12.42
- Operating Margin %
- 33.79%
- Net Margin %
- 19.18%
- ROE %
- 8.94%
- ROCE %
- 12.26%
- 7.78%
- Debtor Days
- 64
- Inventory Days
- 83
- Payable Days
- 58
- 88
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 41.36x
- 9.31x
- Revenue Growth %
- 2.13%
- Operating Profit Growth %
- -12.46%
- Net Profit Growth %
- -16.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 11.92
- Book Value (₹)
- 118.14
- Dividend per Share (₹)
- 5.10
- Cash EPS (₹)
- 15.40
- Operating Margin %
- 32.87%
- Net Margin %
- 21.92%
- ROE %
- 10.72%
- ROCE %
- 14.78%
- 9.34%
- Debtor Days
- 58
- Inventory Days
- 80
- Payable Days
- 50
- 87
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 46.58x
- 7.61x
- Revenue Growth %
- 15.39%
- Operating Profit Growth %
- 32.44%
- Net Profit Growth %
- 31.85%
- 26.19%
- P/E (x)
- 29.15x
- P/B (x)
- 2.94x
- Dividend Yield %
- 1.47%
- 15.62x
Mar 2025
- EPS (₹)
- 11.72
- Book Value (₹)
- 126.56
- Dividend per Share (₹)
- 5.20
- Cash EPS (₹)
- 15.24
- Operating Margin %
- 30.70%
- Net Margin %
- 21.04%
- ROE %
- 9.79%
- ROCE %
- 13.76%
- 8.55%
- Debtor Days
- 61
- Inventory Days
- 88
- Payable Days
- 42
- 107
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 41.44x
- 9.14x
- Revenue Growth %
- 2.09%
- Operating Profit Growth %
- -5.68%
- Net Profit Growth %
- -2.17%
- -1.69%
- P/E (x)
- 23.80x
- P/B (x)
- 2.20x
- Dividend Yield %
- 1.86%
- 13.28x
Mar 2026
- EPS (₹)
- 15.07
- Book Value (₹)
- 144.99
- Dividend per Share (₹)
- 5.35
- Cash EPS (₹)
- 19.09
- Operating Margin %
- 30.69%
- Net Margin %
- 23.24%
- ROE %
- 11.43%
- ROCE %
- 15.27%
- 10.08%
- Debtor Days
- 64
- Inventory Days
- 82
- Payable Days
- 56
- 89
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 63.28x
- 9.78x
- Revenue Growth %
- 17.09%
- Operating Profit Growth %
- 15.95%
- Net Profit Growth %
- 29.58%
- 28.63%
- P/E (x)
- 16.94x
- P/B (x)
- 1.76x
- Dividend Yield %
- 2.09%
- 10.43x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-18 - Advanced Enzyme Technologies Limited has informed the Exchange about Transcript
- General Updates
2026-08-13 - Advanced Enzyme Technologies Limited has informed the Exchange about General Updates
Annual Reports
Credit Ratings
- Credit Rating
2026-05-06 - Advanced Enzyme Technologies Limited has informed the Exchange about Credit Rating
Concalls
Aug 2026
May 2026
Feb 2026